1.
Rath J, Geisler C, Christiansen CB, Hastrup N, Madsen HO, Andersen MK, Pedersen LB, Jurlander J. Epstein-Barr virus reactivation is a potentially severe complication in chronic lymphocytic leukemia patients with poor prognostic biological markers and fludarabine refractory disease. Haematologica 2008; 93(9):1424-1426; https://doi.org/10.3324/haematol.13059.